Publishing News and Press Releases
(Publishing-NewsWire.com, January 09, 2020 ) According to the new research report "The Probiotics in animal feed market to grow from USD 4.6 billion in 2019 to USD 7.0 billion by 2025, at a Compound Annual Growth Rate (CAGR) of 7.4% during the forecast period. The major factors that are expected to be driving the probiotics in animal feed market are the Growth in consumption of animal-based products, shift of livestock industry from unorganized sector to an organized one, increase in focus on animal health to prevent disease outbreaks. The objective of the report is to define, describe, and forecast the probiotics in animal feed market size based on livestock (poultry, ruminants, swine, aquaculture, pets), source (bacteria [lactobacilli, streptococcus thermophilus, bifidobacteria] and yeast.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=85832335
The bacteria segment is estimated to account for a larger market share, in terms of value, in 2019
Based on source, the probiotics in animal feed market is segmented into bacteria and yeast & fungi. The survival rate of bacterial strains within the gastrointestinal tract of animals is much higher as compared to yeast. Hence, bacterial strains are more preferred in the production of probiotics in animal feed.
Opportunity: Ban on the use of AGPs (Antibiotic feed promoters) in animal feed
In 2006, the European Union (EU) implemented a ban on the use of antibiotics in animal feed. Antibiotic growth promoters (AGP) are chemicals/drugs that are added to animal feed to improve growth and the quantity of animal produce. According to the EU, the use of these drugs led to the development of antibiotic-resistant microbes to treat infections in humans and animals.
Following this ban by the EU, the use of antibiotics declined in many countries around the globe, especially in countries such as China, India, and the US due to their overexploitation or misuse. In January 2017, the US Food and Drug Administration (USFDA) banned the usage of antibiotics as feed supplements to help livestock and poultry grow faster. The new regulations also state that the over-the-counter sales of antibiotics used in feed is prohibited.
Challenge: High R&D costs for developing new probiotic strains
Substantial investments in R&D activities and investments in laboratories, research equipment, and the high cost of hiring trained professionals create barriers for the development of the market for probiotics in animal feed. The scientific validation regarding the usage of probiotics in their applications becomes a success to this market. Probiotic applications are linked with health benefits, which make it challenging for manufacturers to get an adequate return on high initial investments. Key companies such as Chr. Hansen (Denmark) and DowDuPont (US) have focused their strategies on building a strong R&D base to gain a competitive advantage, which has created a barrier for other players in the market for probiotics in animal feed.
Request for Customization: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=85832335
The Asia Pacific region is projected to dominate the market through the forecast period
In 2018, the Asia Pacific region led the global probiotics in animal feed market. Factors such as a large livestock base, high meat consumption, and increasing consumer awareness about the positive impact of probiotics on animal health are driving the Asia Pacific market. Some of the countries contributing to the growth of this region include China, India, Japan, Australia, and New Zealand.
This report includes a study on the marketing and development strategies, along with a study on the product portfolios of the leading companies operating in the probiotics in animal feed market. It includes the profiles of leading companies such as Chr. Hansen (Denmark), Koninklijke DSM N.V. (Netherlands), DowDuPont (US), Evonik Industries (Germany), Land OLakes (US). Other players include Lallemand (Canada), Bluestar Adisseo Co. (China), Lesaffre (France), Alltech (US), Novozymes (Denmark), Calpis Co., Ltd. (Japan), Schouw & Co. (Denmark), Unique Biotech (India), Pure Cultures (US), Kerry (Ireland), and Mitsui & Co., Ltd. (Japan).
Chr. Hansen develops natural ingredients for food, nutritional, pharmaceutical, and agricultural industries. The company provides products such as cultures, enzymes, and probiotics to the animal feed and food & beverage industries. The company’s major business segments include cultures & enzymes, natural colors, and health & nutrition. It has the largest commercial collection of bacteria, with over 30,000 bacterial strains. The company produces probiotics for feed under its Health & Nutrition division. Within animal feed, it provides probiotics for poultry, swine, and cattle.
Mr. Shelly Singh